Document:

EXHIBIT 10.11

                                NOVEON, INC.
                       2002 MANAGEMENT INCENTIVE PLAN

PURPOSE
-------

The Noveon,  Inc. 2002  Management  Incentive  Plan  (referred to herein as
"2002  MIP,"  "MIP,"  or  the  "Plan")  has  been  established  to  provide
opportunities  for  certain  selected   management   employees  to  receive
incentive  compensation as a reward for high levels of personal performance
above the ordinary performance  standards compensated by base salary. While
the  amount  of  compensation  at risk may vary by  position  level or work
country,  the purpose of the MIP is to more closely align  compensation  of
key employees to Company performance.

ELIGIBILITY
-----------

Participation  in MIP will be limited to management  employees who have the
potential  to  influence  the  performance  of the  Company  or the  Global
Business  Unit  (GBU) to  which  they are  assigned.  Participants  will be
selected and approved by the President & CEO annually. Inclusion in the MIP
does not assure that an individual will receive an incentive award nor does
it guarantee an individual  participation  in the MIP in future years.  Any
incentive award under this Plan is entirely  discretionary.  Employees must
be on the payroll before September 1, 2002, to participate in the 2002 MIP.

PARTICIPATION CATEGORIES
------------------------

Each  participant  in the MIP will be  assigned  an  incentive  opportunity
level.  The target  incentive  percentage  will be based upon the  assigned
level of the position and the country where the participant works.

In the United States,  changes to the assigned MIP target  percentages  for
executive  officers  will be  recommended  by  President  & CEO and will be
approved by the Compensation Committee of the Board of Directors.  Other US
participants will have target percentages  between 20% and 45% depending on
assigned pay level. In other countries, the assigned MIP target percentages
will  range  from  4% to  25%  depending  on  position.  Individual  target
percentages   will  be  assigned   based  upon  local   practice  and  each
participant's  pay  level.  The NLT will have  overall  responsibility  for
approving  the  target MIP  percentages  for all  participants,  other than
executive officers and other direct reports to the President & CEO.

PERFORMANCE MEASURES
--------------------

The 2002 MIP performance measures are set forth in Attachment 1 hereto.

DETERMINATION OF FINANCIAL/PERFORMANCE AWARDS
---------------------------------------------

The  calculation  of 2002 MIP  awards  will be based on the  weighting  and
percentages set forth in Attachment 2 hereto.

Linear interpolation shall be used to determine the MIP award to the extent
that the actual  EBITDA or Working  Capital  amounts fall between or exceed
the  amounts  shown in the table  above and there will be no top end cap to
the EBITDA or Working Capital components of the 2002 MIP.

Any MIP  awards  will be  calculated  based  upon the  actual  base  salary
(excluding  any  other  bonuses,  awards,  or other  types of  supplemental
compensation)  of the  participant as in effect on the last day of the Plan
year.

PAYMENT OF INCENTIVE AWARDS
---------------------------

Payment of any incentive  awards will be based upon  accomplishment  of the
established MIP performance measures.

Within  approximately  ninety (90) days of the close of the financial year,
overall  results  will be  calculated  and  any  incentive  awards  will be
determined  and paid to the  participant  in a single  cash  bonus  payment
through the Company's regular payroll process, subject to payroll taxes and
other appropriate withholdings.

In order to  receive  an  incentive  award,  a  participant  must be on the
payroll  on the  date  that any  incentive  awards  are  paid.  Any  unpaid
incentive award previously communicated shall be forfeited upon termination
of  employment   before  the  incentive  award  payment  date  unless  such
termination is due to retirement, disability or death.

Payment of MIP awards is  discretionary  and the Board of Directors has the
right  to  modify  or  revise  financial/operational  performance  goals to
recognize  unusual  business  conditions  including,  but not  limited  to,
acquisitions, mergers or divestiture of GBUs.

Final determination of any incentive awards under the 2002 MIP will be made
by the  President  and CEO and approved by the Board of Directors  prior to
communication to participants.

ADMINISTRATIVE PROVISIONS
-------------------------

1.   Individuals who are selected for  participation in the MIP after March
     1st of any Plan  year  will have any  incentive  awards  for that year
     prorated by the number of months they were participants in the Plan.

2.   Individuals who are not  participants in the MIP prior to September 1,
     2002 will not be eligible to participate in the 2002 MIP.

3.   Because  of the  discretionary  nature  of the MIP,  participants  who
     terminate  (other  than  retirement,  disability  or  death)  from the
     Company prior to payment of any incentive  awards will not be eligible
     to receive an award from the 2002 MIP.

4.   Individual  participants  (or their  heirs)  who either  elect  normal
     retirement, or are totally disabled (as defined in Section 6 below) or
     die will be eligible to receive a prorated incentive award if an award
     is paid.  The  amount of any  incentive  award  will be based upon the
     number of months that the individual was an active  participant in the
     MIP.

5.   Retirement,  for  purposes  of  this  Plan,  shall  involve  the  same
     determinations and eligibility requirements set forth for a Retirement
     Benefit as provided in the Noveon Pension Plan for Salaried Employees.

6.   Totally  disabled,  for purposes of this Plan,  shall involve the same
     determinations  and eligibility  requirements for a Disability Benefit
     as provided in the Noveon Pension Plan for Salaried Employees.

7.   In the case of a  participant's  death before  payment of a previously
     announced  incentive  award, the incentive award payment shall be paid
     in a lump sum to the participant's estate.

8.   Participants who change positions or assigned  business unit will have
     any MIP award pro-rated taking into consideration the number of months
     during the Plan year they were assigned to different business units or
     at different MIP target incentive levels.

9.   Individual  participants whose employment with Noveon is terminated as
     a result of the sale of their  assigned  business unit will be handled
     on a  case-by-case  basis and a decision on any MIP award will be made
     by Board of Directors.

10.  Participation in the Plan is  discretionary  and inclusion in the 2002
     MIP or  payment  of any  incentive  awards  is no  promise  of  future
     participation in the MIP nor is it a promise of future employment with
     Noveon. Participation in the MIP does not diminish the Company's right
     to  discharge  any  participant  regardless  of the  effect  that such
     discharge  may have upon  him/her  as a  participant  in this MIP.  No
     member of the Company's  Board of Directors,  the NLT, nor any officer
     or  employee  shall be liable to any person  for any  action  taken or
     omitted in connection with the administration of this Plan.

11.  Plan year means the Company's  fiscal year as now established or as it
     may be changed from time to time hereafter.

12.  Prior to the actual payment of any incentive award under this Plan, no
     interest  of any  participant  in this Plan  shall be  subject  in any
     manner to sale, transfer, assignment, pledge, attachment, garnishment,
     or other alienation or encumbrances of any kind; nor may such interest
     in  any  incentive  award  prior  to  its  payment  be  taken,  either
     voluntarily or involuntarily  for the satisfaction of the debts of, or
     other  obligations  or claims  against,  such  participant,  including
     claims  for  alimony,  support,  separate  maintenance,  and claims in
     bankruptcy proceedings.

13.  At all times,  this Plan shall be entirely  unfunded  and no provision
     shall at any time be made with  respect to  segregating  any assets of
     the Company for payment of any awards  hereunder.  With respect to any
     claim for an unpaid but previously  communicated incentive award under
     this  Plan,  a  participant  is a general  unsecured  creditor  of the
     Company.

BINDING EFFECT
--------------

This Plan shall be binding upon the beneficiaries,  heirs,  executors,  and
administrators  of the  participant.  Nothing  contained in this Plan shall
constitute a guaranty by the Company or any other person or entity that the
assets  of the  Company  will  be  sufficient  to pay any  incentive  award
hereunder.

AMENDMENT AND TERMINATION
-------------------------

The Company's  Board of Directors may at any time  terminate  this Plan, in
whole or in part, or amend it from time to time.  Any such  termination  or
amendment may be made retroactively.

PLAN GOVERNANCE
---------------

The Board of Directors  maintains  the right to modify or terminate the MIP
at any future date.  The  Compensation  Committee of the Board of Directors
will resolve any disputes or questions  regarding the administration of the
MIP (including the  interpretation  of ambiguous terms) and their decisions
will be final and binding on all parties.  A participant shall not have any
right to receive a payment of benefits under this Plan except in accordance
with the terms of the Plan.  In the event that any  provisions  of the Plan
shall be held to be  invalid  by any  competent  court,  this Plan shall be
interpreted as if such provision was not contained herein.

Adopted on the 21st day of January, 2002.

NOVEON, INC.

By: /s/ Christopher R. Clegg
    -------------------------------------
    Christopher R. Clegg, Senior Vice
       President and SecretaryHANGER ORTHOPEDIC GROUP, INC.
                      Non-Qualified Stock Option Agreement
                      ------------------------------------

       THIS AGREEMENT is made as of December 12, 2001, by and between HANGER
ORTHOPEDIC GROUP, INC., a Delaware corporation (the "Company"), and Jay Alix &
Associates, Inc. (the "Optionee").

                              W I T N E S S E T H:
                               -------------------

       WHEREAS, the Company desires to grant to the Optionee a non-qualified
stock option to purchase One Million Two Hundred Two Thousand Four Hundred
Thirty-Six (1,202,436) shares of the Company's common stock, par value $.01 per
share (the "Common Stock"), in consideration for services rendered to the
Company by the Optionee pursuant to the terms of the letter agreement, dated
January 23, 2001 (the "Letter Agreement"), between the Company and the Optionee.

       NOW, THEREFORE, the parties hereto, intending to be legally bound, do
agree as follows:

       1. Grant of Option. Subject to the terms and conditions of this
Agreement, the Company hereby grants to Optionee the right and option to
purchase from the Company all or part of an aggregate of One Million Two Hundred
Two Thousand Four Hundred Thirty-Six (1,202,436) shares of Common Stock. This
option is not intended to qualify as an incentive stock option within the
meaning of Section 422A of the Internal Revenue Code of 1986, as amended.

       2. Option Price and Time of Exercise. The per-share purchase price at
which the shares subject to option hereunder may be purchased by Optionee
pursuant to its exercise of this option shall be $1.40, which price equals the
average closing price per share of the Common Stock on the New York Stock
Exchange for all trading days during the period from December 23, 2000 through
January 23, 2001, as required under the terms of the Letter Agreement. The
Optionee's right to exercise this option shall not vest until June 18, 2002,
from and after which time the Optionee may exercise this option in whole or in
part at any time prior to the expiration of this option on May 31, 2007 (the
"Option Period"). The right to exercise this option shall be cumulative to the
extent not theretofore exercised.

       3. Method of Exercise and Payment for Shares. This option shall be
exercised by written notice from the Optionee and delivered to the Company at
its principal office, specifying the number of shares to be acquired upon such
exercise and delivering therewith by wire transfer of funds or a certified check
in an amount equal to the exercise price of the option multiplied by the number
of shares of Common Stock to be acquired upon such exercise of the option by the
Optionee.

       4. Non-transferability of Option; Restricted Securities. This option is
not transferable by Optionee, except only after the written consent of the
Company, which shall not

<PAGE>

be unreasonably withheld, in connection with a merger of the Optionee or the
transfer by the Optionee of all or substantially all of its assets (including
this option), in which event this option may be transferred by the Optionee to
such successor after the issuance of the written consent of the Company. The
shares of Common Stock acquired by Optionee upon any exercise of this option
shall be "restricted securities" within the meaning of Rule 144(a)(3) under the
Securities Act of 1933 and Optionee shall be required to comply with and satisfy
all applicable laws in any resale transactions conducted by Optionee which
involve any such shares of Common Stock so acquired by Optionee under this
option.

       5. Merger, Consolidation, Acceleration of Option Vesting.

       (a) Effect of Transaction. Upon the occurrence of any of the following
events, if the notice required by Section 5(b) hereof shall have first been
given, the option granted hereunder shall automatically terminate and be of no
further force and effect whatsoever, without the necessity for any additional
notice or other action by the Company: (i) the merger, consolidation or
liquidation of the Company or the acquisition of its assets or stock pursuant to
a nontaxable reorganization, unless the surviving or acquiring corporation, as
the case may be, shall assume all outstanding options of the Company or
substitute new options for them pursuant to Section 425(a) of the Code; (ii) the
dissolution or liquidation of the Company; (iii) the appointment of a receiver
for all or substantially all of the Company's assets or business; (iv) the
appointment of a trustee for the Company after a petition has been filed for the
Company's reorganization under applicable statutes; or (v) the sale, lease or
exchange of all or substantially all of the Company's assets and business.

       (b) Notice of Such Occurrences. At least 30 days' prior written notice of
any event described in Section 6(a) hereof, except the transactions described in
subsections 5(a)(iii) and (iv) as to which no notice shall be required, shall be
given by the Company to the Optionee. If the Optionee is so notified, it may
exercise all or a portion of the entire unexercised portion of this option at
any time before the occurrence of the event requiring the giving of notice,
regardless of whether such event occurs prior to June 18, 2002. Such notice
shall be deemed to have been given when delivered personally to the Optionee or
when mailed to the Optionee by registered or certified mail, postage prepaid, at
the Optionee's last address known to the Company.

       6. Adjustments Upon Certain Events. If the Company shall at any time
increase or decrease the number of its outstanding shares of Common Stock by
means of the payment of a stock dividend, a stock split or subdivision of
shares, a consolidation or combination of shares, or through a reclassification
of the then outstanding shares of Common Stock, then the aggregate number of
shares of Common Stock subject to this Option and the exercise price of this
Option shall be adjusted proportionately.

       7. Binding Effect, Entire Agreement. Subject to the limitations stated
above, this Agreement shall be binding upon and inure to the benefit of the
Optionee (and its successor as provided in Section 4 of this Agreement) and the
Company. This Agreement constitutes the entire agreement between the parties and
cannot be altered, modified, or changed in any way

                                       2
<PAGE>

unless made in writing and signed by the party against whom such alteration,
modification, or change is asserted. This Agreement shall be governed by the
laws of the State of Delaware.

       IN WITNESS WHEREOF, the Company has caused this Agreement to be signed by
its President and attested by its Secretary, and the Optionee has affixed its
signature hereto.

HANGER ORTHOPEDIC GROUP, INC.

By:  /s/ George McHenry
   ---------------------------------
      George McHenry
      Executive Vice President &
           Chief Financial Officer

ACCEPTED BY:

JAY ALIX & ASSOCIATES, INC.

By:  /s/ Melvin R. Christiansen
   ---------------------------------
      Melvin R. Christiansen
      Treasurer

                                       3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00039-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00039-of-00352.parquet"}]]